Bioactive components from Sinomenium acutum exhibit anti-inflammatory activity and sensitize cervical cancer cells to paclitaxel
Xilei Wang, Chengjing Zhu, Xinyu Du, Qiang Wang, Jianqing Yu · 2026
Read Bioactive components from Sinomenium acutum exhibit anti-inflammatory activity and sensitize cervical cancer cells to paclitaxel by Xilei Wang, Chengjing Zhu, Xinyu Du, Qiang Wang, Jianqing Yu (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13680603.txt.
Description
Xilei Wang and co-authors isolate active compounds from the plant Sinomenium acutum and test them against inflammation and drug-resistant cervical cancer cells. The team extracts eighteen compounds in all: six never described before and twelve already known. Their structures are pinned down with spectroscopy, carbon-13 calculations, and X-ray diffraction of crystals. The group then screens the compounds for biological activity.
Nine compounds calm inflammation more strongly than the standard control drug indomethacin. Mapping which structural features track with strength gives clues for designing new anti-inflammatory drugs. Five compounds also reverse resistance to the chemotherapy drug paclitaxel in a resistant cervical cancer cell line. One compound, paired with paclitaxel, pushes the cancer cells toward programmed death. The authors present the plant as a source of leads for both anti-inflammatory and cancer support drugs.
Catalog record
| CREATOR | Xilei Wang, Chengjing Zhu, Xinyu Du, Qiang Wang, Jianqing Yu |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 40 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |